{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:47:41Z","timestamp":1784994461996,"version":"3.55.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M652658"],"award-info":[{"award-number":["2019M652658"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671195"],"award-info":[{"award-number":["31671195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971066"],"award-info":[{"award-number":["31971066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118761","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T03:02:58Z","timestamp":1605150178000},"page":"118761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Nano-based approaches in the development of antiviral agents and vaccines"],"prefix":"10.1016","volume":"265","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6797","key":"10.1016\/j.lfs.2020.118761_bb0005","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35021206","article-title":"Changing patterns of infectious disease","volume":"406","author":"Cohen","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2020.118761_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3201\/eid1906.130192","article-title":"Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome","volume":"19","author":"Braden","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118761_bb0015","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.118761_bb0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijbiomac.2020.06.274","article-title":"Copper and iron ions accelerate the prion-like propagation of alpha-synuclein: a vicious cycle in Parkinson\u2019s disease","volume":"163","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"10225","key":"10.1016\/j.lfs.2020.118761_bb0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118761_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcaa258","article-title":"COVID-19 & chronic renal disease: clinical characteristics & prognosis","author":"Yang","year":"2020","journal-title":"QJM"},{"issue":"6812","key":"10.1016\/j.lfs.2020.118761_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"issue":"6304","key":"10.1016\/j.lfs.2020.118761_bb0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41579-019-0233-2","article-title":"Therapeutic strategies to target the Ebola virus life cycle","volume":"17","author":"Hoenen","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","article-title":"Clinical significance of chemokine receptor antagonists","volume":"16","author":"Miao","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/v12030276","article-title":"Influenza a virus antibodies with antibody-dependent cellular cytotoxicity function","volume":"12","author":"Gao","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2020.118761_bb0065","article-title":"Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","author":"Huo","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/c2pp05414k","article-title":"Photocatalytic inactivation of influenza virus by titanium dioxide thin film","volume":"11","author":"Nakano","year":"2012","journal-title":"Photochem Photobiol Sci"},{"issue":"7","key":"10.1016\/j.lfs.2020.118761_bb0075","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/acsnano.8b01616","article-title":"Multivalent flexible nanogels exhibit broad-spectrum antiviral activity by blocking virus entry","volume":"12","author":"Dey","year":"2018","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40121-013-0014-6","article-title":"The problems with polio: toward eradication","volume":"2","author":"Lien","year":"2013","journal-title":"Infect. Dis. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.vaccine.2017.01.031","article-title":"Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis a vaccine in adults: a 20-year follow-up study","volume":"35","author":"Chappuis","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0090","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","article-title":"The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015","volume":"36","author":"Pezzotti","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lfs.2020.118761_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s12038-009-0114-3","article-title":"Nanovaccines: recent developments in vaccination","volume":"34","author":"Nandedkar","year":"2009","journal-title":"J. Biosci."},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/vaccines4040045","article-title":"Synthetic biodegradable microparticle and nanoparticle vaccines against the respiratory syncytial virus","volume":"4","author":"Jorquera","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2020.118761_bb0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 \u2014 preliminary report","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118761_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-981-15-0606-2_5","article-title":"Autophagy and viral infection","volume":"1209","author":"Mao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/v12020161","article-title":"Differential features of fusion activation within the Paramyxoviridae","volume":"12","author":"Azarm","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0125","doi-asserted-by":"crossref","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","article-title":"Hepatitis C virus replication","volume":"10","author":"Tabata","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1039\/C7BM01020F","article-title":"Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications","volume":"6","author":"Jiao","year":"2018","journal-title":"Biomaterials Science"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0135","article-title":"Actively targeted deep tissue imaging and Photothermal-chemo therapy of breast Cancer by antibody-functionalized drug-loaded X-ray-responsive bismuth sulfide@Mesoporous silica Core-Shell nanoparticles","volume":"28","author":"Li","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0140","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/acsnano.0c01665","article-title":"Cell-membrane-mimicking Nanodecoys against infectious diseases","volume":"14","author":"Rao","year":"2020","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113691","article-title":"Nef neutralizes the ability of exosomes from CD4+ T cells to act as decoys during HIV-1 infection","volume":"9","author":"de Carvalho","year":"2014","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.lfs.2020.118761_bb0150","doi-asserted-by":"crossref","first-page":"12499","DOI":"10.1002\/anie.201807212","article-title":"Bioinspired artificial nanodecoys for hepatitis B virus","volume":"57","author":"Liu","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0155","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/ijms17081296","article-title":"Binding and fusion of extracellular vesicles to the plasma membrane of their cell targets","volume":"17","author":"Prada","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"45","key":"10.1016\/j.lfs.2020.118761_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802233","article-title":"T-cell-mimicking nanoparticles can neutralize HIV infectivity","volume":"30","author":"Wei","year":"2018","journal-title":"Adv. Mater."},{"issue":"33","key":"10.1016\/j.lfs.2020.118761_bb0165","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1002\/anie.201906280","article-title":"Inhibition of pathogen adhesion by bacterial outer membrane-coated nanoparticles","volume":"58","author":"Zhang","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0170","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1021\/acs.nanolett.8b03913","article-title":"A biomimetic Nanodecoy traps Zika virus to prevent viral infection and fetal microcephaly development","volume":"19","author":"Rao","year":"2019","journal-title":"Nano Lett."},{"issue":"27","key":"10.1016\/j.lfs.2020.118761_bb0175","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2020.118761_bb0180","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","article-title":"Cellular Nanosponges inhibit SARS-CoV-2 infectivity","volume":"20","author":"Zhang","year":"2020","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0185","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0190","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157016212803901383","article-title":"Gold nanoparticles as an HIV entry inhibitor","volume":"10","author":"Vijayakumar","year":"2012","journal-title":"Curr. HIV Res."},{"issue":"26","key":"10.1016\/j.lfs.2020.118761_bb0195","doi-asserted-by":"crossref","first-page":"16564","DOI":"10.1021\/acsami.6b03342","article-title":"Viral inhibition mechanism mediated by surface-modified silica nanoparticles","volume":"8","author":"de Souza","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4014\/jmb.1508.08024","article-title":"In vitro antiviral activity of Cinnamomum cassia and its nanoparticles against H7N3 influenza a virus","volume":"26","author":"Fatima","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0210","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.4238\/2014.March.19.2","article-title":"Inhibition effect of silver nanoparticles on herpes simplex virus 2","volume":"13","author":"Hu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.lfs.2020.118761_bb0215","first-page":"4303","article-title":"Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3","volume":"8","author":"Gaikwad","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104113","article-title":"Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection","volume":"9","author":"Orlowski","year":"2014","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.lfs.2020.118761_bb0225","doi-asserted-by":"crossref","first-page":"16192","DOI":"10.1039\/C6NR03878F","article-title":"GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses","volume":"8","author":"Lee","year":"2016","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.lfs.2020.118761_bb0230","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2020.118761_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115261","article-title":"Polyphosphonium-oligochitosans decorated with nanosilver as new prospective inhibitors for common human enteric viruses","volume":"226","author":"Sofy","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0240","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/bm3016658","article-title":"Glycofullerenes inhibit viral infection","volume":"14","author":"Luczkowiak","year":"2013","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nchem.2387","article-title":"Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection","volume":"8","author":"Munoz","year":"2016","journal-title":"Nat. Chem."},{"issue":"32","key":"10.1016\/j.lfs.2020.118761_bb0250","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1039\/C7TB01379E","article-title":"Antiviral activity of self-assembled glycodendro[60]fullerene monoadducts","volume":"5","author":"Munoz","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.lfs.2020.118761_bb0255","doi-asserted-by":"crossref","unstructured":"X. Ji, G.G. Olinger, S. Aris, Y. Chen, H. Gewurz, and G.T. Spear, Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol, 86 (Pt 9) (2005) 2535\u20132542.","DOI":"10.1099\/vir.0.81199-0"},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0260","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","article-title":"Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns","volume":"79","author":"Huang","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41598-017-00675-x","article-title":"Carbon Dots\u2019 antiviral functions against Noroviruses","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1109\/TNB.2015.2508718","article-title":"Gold nanoparticles impair foot-and-mouth disease virus replication","volume":"15","author":"Rafiei","year":"2016","journal-title":"IEEE Trans Nanobioscience"},{"key":"10.1016\/j.lfs.2020.118761_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","author":"Luther","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0280","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/AAC.00341-16","article-title":"Fullerene derivatives strongly inhibit HIV-1 replication by affecting virus maturation without impairing protease activity","volume":"60","author":"Martinez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2020.118761_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2014.06.011","article-title":"Silver nanoparticles impair Peste des petits ruminants virus replication","volume":"190","author":"Khandelwal","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.lfs.2020.118761_bb0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/IJN.S122842","article-title":"Biological activity of green-synthesized silver nanoparticles depends on the applied natural extracts: a comprehensive study","volume":"12","author":"Ronavari","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2020.118761_bb0295","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.carbon.2016.09.032","article-title":"Carbon dots as inhibitors of virus by activation of type I interferon response","volume":"110","author":"Du","year":"2016","journal-title":"Carbon"},{"issue":"32","key":"10.1016\/j.lfs.2020.118761_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201700818","article-title":"Reactive oxygen species-regulating Polymersome as an antiviral agent against influenza virus","volume":"13","author":"Kim","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.lfs.2020.118761_bb0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.virol.2016.12.011","article-title":"Viral exploitation of the MEK\/ERK pathway - a tale of vaccinia virus and other viruses","volume":"507","author":"Bonjardim","year":"2017","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0310","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/10\/105101","article-title":"Light-activated nanotube-porphyrin conjugates as effective antiviral agents","volume":"23","author":"Banerjee","year":"2012","journal-title":"Nanotechnology"},{"issue":"38","key":"10.1016\/j.lfs.2020.118761_bb0315","doi-asserted-by":"crossref","first-page":"21571","DOI":"10.1021\/acsami.5b06876","article-title":"Antiviral activity of Graphene oxide: how sharp edged structure and charge matter","volume":"7","author":"Ye","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0320","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1134\/S1995078010050174","article-title":"Interaction of titanium dioxide nanoparticles with influenza virus","volume":"5","author":"Mazurkova","year":"2010","journal-title":"Nanotechnologies in Russia"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/ijerph13040430","article-title":"Antiviral activity of graphene-silver nanocomposites against non-enveloped and enveloped viruses","volume":"13","author":"Chen","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.lfs.2020.118761_bb0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcis.2017.02.059","article-title":"Inactivation of MS2 bacteriophage by titanium dioxide nanoparticles in the presence of quartz sand with and without ambient light","volume":"497","author":"Syngouna","year":"2017","journal-title":"J. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0335","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1021\/es102749e","article-title":"Simple route to enhanced photocatalytic activity of p25 titanium dioxide nanoparticles by silica addition","volume":"45","author":"Jafry","year":"2011","journal-title":"Environ Sci Technol"},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0340","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AEM.03427-13","article-title":"Antiviral properties of silver nanoparticles on a magnetic hybrid colloid","volume":"80","author":"Park","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.lfs.2020.118761_bb0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jviromet.2016.12.015","article-title":"Cytotoxicity and antiviral activity of electrochemical - synthesized silver nanoparticles against poliovirus","volume":"241","author":"Huy","year":"2017","journal-title":"J. Virol. Methods"},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141050","article-title":"Antiviral activity of gold\/copper sulfide Core\/Shell nanoparticles against human Norovirus virus-like particles","volume":"10","author":"Broglie","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0355","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nrmicro2332","article-title":"A look behind closed doors: interaction of persistent viruses with dendritic cells","volume":"8","author":"Lambotin","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0360","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.lfs.2020.118761_bb0365","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fimmu.2014.00359","article-title":"Strategies for designing and monitoring malaria vaccines targeting diverse antigens","volume":"5","author":"Barry","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0370","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejpb.2011.10.016","article-title":"Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I his-gag p41 and systemic inflammatory responses","volume":"80","author":"Wadhwa","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0375","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1021\/nn304235j","article-title":"Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses","volume":"7","author":"Zaric","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0380","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0385","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138920372005190327120752","article-title":"Clinical applications of virus-like particles: opportunities and challenges","volume":"20","author":"Yang","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","article-title":"Exploiting virus-like particles as innovative vaccines against emerging viral infections","volume":"55","author":"Jeong","year":"2017","journal-title":"J. Microbiol."},{"issue":"9","key":"10.1016\/j.lfs.2020.118761_bb0395","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol."},{"issue":"11\u221212","key":"10.1016\/j.lfs.2020.118761_bb0400","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0264-410X(99)00351-5","article-title":"HPV6b virus like particles are potent immunogens without adjuvant in man","volume":"18","author":"Zhang","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0405","article-title":"Infections, vaccines and autoimmunity: a multiple sclerosis perspective","volume":"8","author":"Jakimovski","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.lfs.2020.118761_bb0410","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4161\/hv.20042","article-title":"Hepatitis E vaccine development: a 14 year odyssey","volume":"8","author":"Wu","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0415","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2020.118761_bb0420","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.lfs.2020.118761_bb0425","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","article-title":"Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs","volume":"247","author":"Dhakal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2020.118761_bb0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.micpath.2016.05.012","article-title":"Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46","volume":"97","author":"Amirnasr","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2020.118761_bb0435","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","article-title":"Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity","volume":"130","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines4040034","article-title":"Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting","volume":"4","author":"Gutjahr","year":"2016","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.lfs.2020.118761_bb0445","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acsnano.5b02014","article-title":"Antigen-loaded Upconversion nanoparticles for dendritic cell stimulation, tracking, and vaccination in dendritic cell-based immunotherapy","volume":"9","author":"Xiang","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0455","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0460","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0465","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1021\/nn403085w","article-title":"Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation","volume":"7","author":"Molino","year":"2013","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.lfs.2020.118761_bb0470","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.4049\/jimmunol.1001093","article-title":"Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (gamma-glutamic acid) nanoparticles","volume":"187","author":"Mukai","year":"2011","journal-title":"J. Immunol."},{"issue":"47","key":"10.1016\/j.lfs.2020.118761_bb0475","doi-asserted-by":"crossref","first-page":"22748","DOI":"10.1039\/C9NR05549E","article-title":"Biomineralization improves the thermostability of foot-and-mouth disease virus-like particles and the protective immune response induced","volume":"11","author":"Du","year":"2019","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0480","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0485","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/advan.00058.2013","article-title":"Pattern recognition receptors in innate immunity, host defense, and immunopathology","volume":"37","author":"Suresh","year":"2013","journal-title":"Adv. Physiol. Educ."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0490","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s41467-017-02355-w","article-title":"ANGPTL8 negatively regulates NF-kappaB activation by facilitating selective autophagic degradation of IKKgamma","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.lfs.2020.118761_bb0495","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1111\/febs.15202","article-title":"USP15 potentiates NF-kappaB activation by differentially stabilizing TAB2 and TAB3","volume":"287","author":"Zhou","year":"2020","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0500","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4110\/in.2013.13.1.30","article-title":"Induction of potent antigen-specific cytotoxic T cell response by PLGA-nanoparticles containing antigen and TLR agonist","volume":"13","author":"Lee","year":"2013","journal-title":"Immune Netw"},{"issue":"204","key":"10.1016\/j.lfs.2020.118761_bb0505","doi-asserted-by":"crossref","first-page":"204ra130","DOI":"10.1126\/scitranslmed.3006516","article-title":"Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination","volume":"5","author":"Li","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006684","article-title":"Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection","volume":"13","author":"Turner","year":"2017","journal-title":"PLoS Pathog."},{"issue":"46","key":"10.1016\/j.lfs.2020.118761_bb0515","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1016\/j.vaccine.2017.09.076","article-title":"Hepatitis B vaccine and the need for a booster dose after primary vaccination","volume":"35","author":"Pileggi","year":"2017","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.lfs.2020.118761_bb0520","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.vaccine.2017.09.036","article-title":"Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015","volume":"35","author":"Ng","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/CVI.00557-12","article-title":"Antibody responses to vaccination among south African HIV-exposed and unexposed uninfected infants during the first 2 years of life","volume":"20","author":"Reikie","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118761_bb0530","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41565-020-0719-0","article-title":"Role of nanoscale antigen organization on B-cell activation probed using DNA origami","volume":"15","author":"Veneziano","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.lfs.2020.118761_bb0535","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2014.00092","article-title":"Early BCR events and antigen capture, processing, and loading on MHC class II on B cells","volume":"5","author":"Avalos","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0540","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-019-12080-1","article-title":"Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle","volume":"10","author":"Brouwer","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0545","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"38","key":"10.1016\/j.lfs.2020.118761_bb0550","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0555","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1348-0421.12754","article-title":"Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs","volume":"64","author":"Sekimukai","year":"2020","journal-title":"Microbiol. Immunol."},{"issue":"24","key":"10.1016\/j.lfs.2020.118761_bb0560","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","article-title":"Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus","volume":"36","author":"Jung","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2020.118761_bb0565","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","article-title":"Chaperna-mediated assembly of ferritin-based Middle East respiratory syndrome-coronavirus nanoparticles","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"issue":"28","key":"10.1016\/j.lfs.2020.118761_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201807616","article-title":"Viromimetic STING agonist-loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus","volume":"29","author":"Lin","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.lfs.2020.118761_bb0575","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"28;14","author":"Chauhan","year":"2020","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0580","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0585","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0590","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"issue":"11","key":"10.1016\/j.lfs.2020.118761_bb0595","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0600","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/d41573-020-00151-8","article-title":"Evolution of the COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0605","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12981-017-0178-3","article-title":"Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies","volume":"14","author":"Ahmed","year":"2017","journal-title":"AIDS Res. Ther."},{"issue":"21","key":"10.1016\/j.lfs.2020.118761_bb0610","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMp1613362","article-title":"Broadly neutralizing antibodies for HIV-1 prevention or immunotherapy","volume":"375","author":"Caskey","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"406","key":"10.1016\/j.lfs.2020.118761_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal1321","article-title":"Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge","volume":"9","author":"Julg","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2020.118761_bb0620","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/imr.12516","article-title":"Polyvalent vaccine approaches to combat HIV-1 diversity","volume":"275","author":"Korber","year":"2017","journal-title":"Immunol. Rev."},{"issue":"6244","key":"10.1016\/j.lfs.2020.118761_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118761_bb0630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0635","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.vaccine.2016.12.049","article-title":"Nanoparticles decorated with viral antigens are more immunogenic at low surface density","volume":"35","author":"Brewer","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2020.118761_bb0640","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coviro.2017.04.005","article-title":"Inactivated influenza virus vaccines: the future of TIV and QIV","volume":"23","author":"Schotsaert","year":"2017","journal-title":"Curr Opin Virol"},{"issue":"11\u201312","key":"10.1016\/j.lfs.2020.118761_bb0645","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0264-410X(02)00481-4","article-title":"Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine","volume":"21","author":"Muszkat","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0650","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2020.118761_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","article-title":"Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants","volume":"475","author":"Dehghan","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0660","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/vaccines8020229","article-title":"A nanoparticle-poly(I:C) combination adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs","volume":"8","author":"Renu","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0665","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/vim.2015.0144","article-title":"Characterization of immune responses to an inactivated avian influenza virus vaccine Adjuvanted with nanoparticles containing CpG ODN","volume":"29","author":"Singh","year":"2016","journal-title":"Viral Immunol."},{"key":"10.1016\/j.lfs.2020.118761_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197909","article-title":"Foot-and-mouth disease virus: prospects for using knowledge of virus biology to improve control of this continuing global threat","volume":"281","author":"Belsham","year":"2020","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0675","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/acs.nanolett.8b00478","article-title":"Potency of a scalable Nanoparticulate subunit vaccine","volume":"18","author":"Qiao","year":"2018","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.lfs.2020.118761_bb0680","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jmv.25417","article-title":"Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in Guinea pigs","volume":"91","author":"Bai","year":"2019","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0685","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acs.nanolett.7b03893","article-title":"Safe staphylococcal platform for the development of multivalent Nanoscale vesicles against viral infections","volume":"18","author":"Yuan","year":"2018","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.lfs.2020.118761_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005071","article-title":"Precisely molded nanoparticle displaying DENV-E proteins induces robust serotype-specific neutralizing antibody responses","volume":"10","author":"Metz","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"14","key":"10.1016\/j.lfs.2020.118761_bb0695","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","article-title":"A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice","volume":"33","author":"Hunsawong","year":"2015","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.lfs.2020.118761_bb0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003958","article-title":"Immunogenic properties of a BCG Adjuvanted chitosan nanoparticle-based dengue vaccine in human dendritic cells","volume":"9","author":"Hunsawong","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.lfs.2020.118761_bb0705","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12985-016-0598-z","article-title":"Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination","volume":"13","author":"Nantachit","year":"2016","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.lfs.2020.118761_bb0710","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.lfs.2020.118761_bb0715","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acs.nanolett.8b03601","article-title":"Interrogation of antigen display on individual vaccine nanoparticles for achieving neutralizing antibody responses against hepatitis C virus","volume":"18","author":"Bazzill","year":"2018","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.lfs.2020.118761_bb0720","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11596-019-2042-2","article-title":"Rational Design of Hybrid Peptides: a novel drug design approach","volume":"39","author":"Wang","year":"2019","journal-title":"Curr Med Sci"},{"issue":"7","key":"10.1016\/j.lfs.2020.118761_bb0725","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/bph.14572","article-title":"Salvation of the fallen angel: reactivating mutant p53","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118761_bb0730","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fphar.2018.00228","article-title":"Risk assessment and risk minimization in Nanomedicine: a need for predictive, alternative, and 3Rs strategies","volume":"9","author":"Accomasso","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118761_bb0735","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibtech.2016.07.006","article-title":"Breaking down the barriers to precision Cancer Nanomedicine","volume":"35","author":"von Roemeling","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"26","key":"10.1016\/j.lfs.2020.118761_bb0740","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.lfs.2020.118761_bb0745","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.vaccine.2017.02.012","article-title":"MERS-CoV spike nanoparticles protect mice from MERS-CoV infection","volume":"35","author":"Coleman","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.lfs.2020.118761_bb0750","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/pharmaceutics11040188","article-title":"Co-delivery of M2e virus-like particles with influenza Split vaccine to the skin using microneedles enhances the efficacy of cross protection","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:03:57Z","timestamp":1777388637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520315149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":150,"alternative-id":["S0024320520315149"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118761","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-based approaches in the development of antiviral agents and vaccines","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118761"}}